Medexus Pharmaceuticals (MDP) Insider Trading & Ownership C$2.76 -0.04 (-1.43%) (As of 05:28 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades Medexus Pharmaceuticals (TSE:MDP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage9.14%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)C$25,324.00Number OfInsiders Selling(Last 12 Months)0 Get MDP Insider Trade Alerts Want to know when executives and insiders are buying or selling Medexus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MDP Insider Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.>> Register for the Workshop Now Medexus Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/19/2024Kenneth D'entremontDirectorBuy3,000C$2.50C$7,500.008/26/2024Brendon BuschmanSenior OfficerBuy1,400C$2.44C$3,416.006/28/2024Kenneth D'entremontDirectorBuy5,000C$1.80C$9,000.002/13/2024Benoit GravelDirectorBuy3,200C$1.69C$5,408.00 (Data available from 1/1/2013 forward) MDP Insider Trading Activity - Frequently Asked Questions Who is on Medexus Pharmaceuticals's Insider Roster? The list of insiders at Medexus Pharmaceuticals includes Benoit Gravel, Brendon Buschman, and Kenneth D'entremont. Learn more on insiders at MDP. What percentage of Medexus Pharmaceuticals stock is owned by insiders? 9.14% of Medexus Pharmaceuticals stock is owned by insiders. Learn more on MDP's insider holdings. Which Medexus Pharmaceuticals insiders have been buying company stock? The following insiders have purchased MDP shares in the last 24 months: Benoit Gravel (C$5,408.00), Brendon Buschman (C$3,416.00), and Kenneth D'entremont (C$16,500.00). How much insider buying is happening at Medexus Pharmaceuticals? Insiders have purchased a total of 12,600 MDP shares in the last 24 months for a total of C$25,324.00 bought. Medexus Pharmaceuticals Key ExecutivesMr. Kenneth d'EntremontCEO & Director2 recent tradesMr. Marcel Konrad (Age 48)Chief Financial Officer Compensation: $797.12kMr. Ian C. Wildgoose BrownGeneral Counsel & Corporate SecretaryMs. Tina Byers CFAExecutive of Investor RelationsMr. Bill PoncySenior Vice President of Commercial Operations - United StatesMr. Brian PetersVice President of Sales & Marketing - United States More Insider Trading Tools from MarketBeat Related Companies Organigram Insider Buying BioSyent Insider Buying Cardiol Therapeutics Insider Buying HLS Therapeutics Insider Buying SugarBud Craft Growers Insider Buying Decibel Cannabis Insider Buying Willow Biosciences Insider Buying Indiva Insider Buying Entourage Health Insider Buying Aequus Pharmaceuticals Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (TSE:MDP) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medexus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medexus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MDP Stock Alerts